205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
21.69%
Net income growth at 50-75% of MRVL's 41.54%. Martin Whitman would worry about lagging competitiveness unless expansions are planned.
No Data
No Data available this quarter, please select a different quarter.
96.30%
Deferred tax of 96.30% while MRVL is zero at 0.00%. Bruce Berkowitz would see a partial difference that can matter for future cash flow if large in magnitude.
-28.00%
Both cut yoy SBC, with MRVL at -24.02%. Martin Whitman would view it as an industry shift to reduce stock-based pay or a sign of reduced expansions.
140.76%
Well above MRVL's 84.08% if positive yoy. Michael Burry would see a risk of bigger working capital demands vs. competitor, harming free cash flow.
19.70%
AR growth is negative or stable vs. MRVL's 80.14%, indicating tighter credit discipline. David Dodd would confirm it doesn't hamper sales volume.
137.50%
Inventory growth well above MRVL's 158.30%. Michael Burry would suspect potential future write-down risk if demand does not materialize.
291.67%
A yoy AP increase while MRVL is negative at -245.90%. John Neff would see competitor possibly improving relationships or liquidity more rapidly.
205.85%
Lower 'other working capital' growth vs. MRVL's 619.84%. David Dodd would see fewer unexpected short-term demands on cash.
-110.00%
Both negative yoy, with MRVL at -82.45%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
87.79%
Operating cash flow growth at 75-90% of MRVL's 104.89%. Bill Ackman would recommend further refinements to match competitor’s CFO gains.
-23.18%
Negative yoy CapEx while MRVL is 16.74%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
23.18%
Some acquisitions while MRVL is negative at -93.14%. John Neff sees competitor possibly pausing M&A or divesting while the firm invests in new deals.
-7.79%
Both yoy lines negative, with MRVL at -16.04%. Martin Whitman would suspect an environment with fewer attractive securities or a strategic pivot to internal growth.
-27.27%
We reduce yoy sales while MRVL is 89.24%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
-32.87%
We reduce yoy other investing while MRVL is 231.79%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
-6000.00%
We reduce yoy invests while MRVL stands at 90.53%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
100.00%
Debt repayment growth of 100.00% while MRVL is zero at 0.00%. Bruce Berkowitz sees a mild advantage that can reduce interest costs unless expansions demand capital here.
-9.52%
Negative yoy issuance while MRVL is 0.00%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
No Data
No Data available this quarter, please select a different quarter.